Business ❯ Pharmaceuticals

Investment

Manufacturing Corporate Strategy Research and Development AstraZeneca Job Creation Economic Impact Market Expansion International Business Corporate Decisions Clinical Trials Corporate Development Drug Development Supply Chain Biotechnology Life Sciences Private Equity Mergers and Acquisitions Dublin Development Government Funding Global Markets International Expansion Economic Development Research Funding Foreign Direct Investment Healthcare Industry Expansion Plans US Market International Competitiveness U.S. Operations Artificial Intelligence Contract Manufacturing Healthcare Sector Multinational Companies Weight Loss Medications Trade Public Investment Capacity Expansion International Investment Astrazeneca Production Facilities International Operations International Relations

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

The move targets localized production of the oral GLP-1 to strengthen supply ahead of potential approvals.

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

AstraZeneca Pledges $15 Billion China Expansion Through 2030

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030